NIH is still unsure whether fluvoxamine should be used to treat COVID
Dec 22nd 2021 9:21pm EST
The NIH recently acknowledged that fluvoxamine completed a Phase 3 study showing it works that was published in the Lancet Global Health. The study noted that “there was one death in the fluvoxamine group and 12 in the placebo group for the per-protocol population (OR 0·09; 95% CI 0·01–0·47).” In plain English, if you started […]
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.